In this episode of Dosing Through the Downfall, Kelly Hanner exposes what she calls the piggy bank problem, how the FDA declared GLP-1 drug shortages “resolved,” shut down compounding access, and handed Big Pharma billions in cash profits.

We’ll trace the history of GLP-1 medications, from their quiet beginnings as diabetes drugs to today’s weight-loss frenzy and reveal how insurance pullbacks and FDA decisions left patients stuck paying out of pocket.

Then we’ll turn to hormones, why the “normal” lab ranges were designed to keep people sick, the dangers of living at the low end of normal, and how denying hormone replacement creates lifelong patients for the pharmaceutical machine.

Finally, Kelly shares how her approach is different: test, don’t guess; optimize, don’t normalize; and treat the whole person, not the profit margin.

🎙️ Tune in for a fiery episode that connects the dots between corruption, cash flow, and the fight for real health.

Liked what you heard?
🔥 Subscribe to the podcast
🔥 Leave a review to help others find the truth
🔥 Share this episode with a friend who’s done playing by broken rules

🔗 Follow on Instagram: @kelly.dynamicrejuvenation
🔗 Follow on Facebook: https://www.facebook.com/dynamicrejuvenation
🔗 Learn more or book a consult: https://www.dynamicrejuvenation.biz
🎧 This is just the beginning. Let’s keep dismantling the BS, one dose at a time.